Abstract
BACKGROUND: Hypertensive disorders of pregnancy, especially pre-eclampsia (PE), represent an important cause of maternal morbidity and mortality worldwide and mostly in middle and low-income countries. PE occurs in 3 to 5% of all pregnancies and in the presence of severe lfeatures, it is associated with worse outcomes. For treatment of PE with severe features, magnesium sulfate administra…